Skip to main content
Fig. 4 | BMC Immunology

Fig. 4

From: A novel approach for rapid high-throughput selection of recombinant functional rat monoclonal antibodies

Fig. 4

Biological activity of 32D6 RtmAbs. a The reactivity of anti-PD-1 (Rec 32D6 and Hyb 32D6) against his-mPD-1 protein was determined by indirect CEIA. b The blocking activity of anti-PD-1 (Rec 32D6 and Hyb 32D6) was determined by a blocking CEIA. c, d The therapeutic efficacy of anti-PD-1 (Rec 32D6 and Hyb 32D6) was evaluated in a syngeneic tumour model bearing a mouse kidney tumour

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us